BackgroundMinimally invasive surgery is becoming more common and transfemoral transcatheter aortic valve replacement is offered to older patients with multiple comorbidities. Sternotomy is not required but patients must lie flat and still for up to 2 – 3 hours. This procedure is increasingly being performed under conscious sedation with supplementary oxygen, but hypoxia and agitation are commonly observed.MethodsIn this randomised controlled trial, we hypothesised that high-flow nasal oxygen would provide superior oxygenation as compared with our standard practice, 2 l.min-1 oxygen by dry nasal specs. The primary endpoint was the change in arterial partial pressure of oxygen (PaO2) during the procedure. Secondary outcomes included the incidence of oxygen desaturation and patient movements. Results A total of 72 patients were recruited. There was no difference in change in PaO2 from baseline using high-flow compared with standard oxygen therapy: median [IQR] increase from 12.1 (10.0- 15.3 [7.2- 29.8]) to 13.7 (10.8- 18.7 [8.5- 32.3]) kPa vs. decrease from 15.5 (12.4- 19.4 [9.2- 22.8]) to 14.2 (11.9- 19.3 [9.7- 22.8]) kPa, respectively (p= 0.087). There was a lower incidence of oxygen desaturation in the high-flow group (p= 0.037). Patients in the high-flow group moved less frequently (p= 0.006) and assigned a significantly higher comfort score to their treatment (p= < 0.001). ConclusionThis study has demonstrated that high-flow, compared with standard oxygen therapy, does not improve arterial oxygenation over the course of the procedure. There are suggestions that it may improve the secondary outcomes studied. Trial registrationInternational Standard Randomised Controlled Trial Number (ISRCTN) 13804861. Registered 15/4/2019. https://doi.org/10.1186/ISRCTN13804861
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.